Article
OSTEONECROSIS OF THE JAW (ONJ) IN DIFFERENTIATED THYROID CANCER (DTC): A CASE REPORT AFTER ZOLEDRONIC ACID AND LENVATINIB TREATMENT
2021-04-11
Abstract excerpt
Patients with Differentiated Thyroid Cancer (DTC) and bone metastases (BM) have generally poor prognosis and low survival rate. The management is based on radioiodine therapy, local procedures and systemic therapies, such as kinase inhibitors. The use of antiresorptive drugs (bisphosphonates or denosumab) is essential to prevent skeletal-related events (SREs), and improve quality of life. The concomitant associati...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 491449b7-fa1b-5fa3-954a-91e5df704888
- DOI
- 10.32388/irmcki
